12 Men Nuked Their Gut With Antibiotics. Here’s What Came Back, and What Didn’t

A four-day course of last-resort antibiotics can flatten a healthy gut microbiome almost overnight, wiping out beneficial bacteria and letting opportunistic species bloom in their place. The real question is what happens after the antibiotics stop: does the gut community bounce back, or is some of the damage permanent? A study out of the University of Copenhagen that tracked 12 healthy men for six months after a potent antibiotic cocktail found an answer that is mostly reassuring, with one lasting asterisk.

Gut Microbiota Rebounds Within Six Weeks of Antibiotic Exposure

The study, published in Nature Microbiology in 2018, gave 12 healthy young men a four-day course of three antibiotics normally reserved for the sickest hospital patients: meropenem, gentamicin, and vancomycin. Researchers used deep genetic sequencing to track individual bacterial species in stool samples before treatment and repeatedly afterward, out to day 180.

The immediate effect was dramatic. Blooms of opportunistic and pathogenic bacteria, including Enterococcus faecalis and Fusobacterium nucleatum, took over as beneficial groups such as Bifidobacterium species and other butyrate-producing bacteria (which feed the cells lining the colon) were depleted. But the composition of the gut community returned to something close to its pre-treatment state within about a month and a half. Lead researcher Oluf Pedersen, a professor at the University of Copenhagen, described the finding in comments reported by ScienceDaily as evidence that "the gut bacterial community of healthy adults are resilient and able to recover after short-term simultaneous exposure to three different antibiotics."

What Antibiotic Recovery Means Beyond the Hospital

The finding matters well past the small group of men in this trial. Broad-spectrum antibiotics like the three tested here are the default choice when doctors cannot wait for lab results to identify an infection, and they are prescribed to large numbers of patients every year, from ICU admissions to serious pneumonia cases. If a healthy gut microbiome routinely snaps back from that kind of chemical assault, it reframes short-course antibiotic treatment as less permanently costly to the microbiome than earlier, smaller studies had implied.

That said, resilience has limits, and later research suggests those limits can extend far past six months. A 2026 study of nearly 15,000 people in Sweden, published in Nature Medicine, found that certain antibiotics, including clindamycin and fluoroquinolones, were tied to gut bacteria disruptions still measurable four to eight years after use, altering the abundance of 10 to 15 percent of species over that stretch. The two studies used different populations, drugs, and timeframes, but together they suggest recovery speed and recovery completeness are separate questions.

Why 12 Men and Six Months of Sequencing Made This Study Credible

The Copenhagen team's approach was narrow by design, and that narrowness is what makes the data trustworthy rather than merely suggestive. By enrolling only healthy young men with no other confounding health conditions and giving all of them the identical four-day drug combination, the researchers isolated the antibiotic effect from the noise of underlying illness, comorbid medications, and mixed dosing that complicates most real-world antibiotic studies. Repeated stool sampling out to day 180, combined with strain-level genetic sequencing rather than broad taxonomic categories, let them track not just whether "gut bacteria" recovered in general but which specific species did and did not come back.

The Study's Blind Spots: No Women, No Placebo Arm

The design that made the results clean also limits how far they generalize. All 12 participants were men, so the findings say nothing directly about whether women's gut microbiomes respond the same way. There was no control or placebo group; every participant received the antibiotic cocktail and was compared only to his own pre-treatment baseline, a legitimate before-and-after design that cannot fully rule out that some of the measured shifts reflect ordinary fluctuation over six months rather than the drugs themselves. And most consequentially, the antibiotic combination tested here, meropenem, gentamicin, and vancomycin, is a specific last-resort regimen; the results may not transfer to the shorter, narrower-spectrum courses, like amoxicillin, that most people actually receive.

Nine bacterial species that were present in all 12 men before treatment were still undetectable in most of them six months later. The study did not report follow-up beyond that six-month mark, so whether those species eventually return, or represent a lasting loss for this group, remains an open question.

What Comes Next for Gut Microbiome Research

A 2023 review in Nature Reviews Microbiology on antibiotic perturbations to the gut microbiome makes a related point: even when species diversity recovers, the functional and genetic profile of the community, including which antibiotic-resistance genes persist, can remain altered. That distinction matters here too. The Copenhagen study also found that bacteria carrying beta-lactam resistance genes were positively selected for during and after treatment, meaning the antibiotics did not just reshuffle the gut community, they nudged its long-term genetic makeup toward drug resistance.

The practical takeaway for now is a cautiously optimistic one: a healthy gut given one short course of powerful antibiotics is more resilient than the "wipes out your microbiome for good" framing sometimes suggests, but resilient is not the same as unaffected. Whether the handful of species that stayed missing at six months matter for digestion, immunity, or anything else measurable is exactly the kind of longer, larger, more diverse study that has not been done yet.

References

1. Albert Palleja, Kristian H. Mikkelsen, Sofia K. Forslund, et al. (2018). Recovery of gut microbiota of healthy adults following antibiotic exposure. Nature Microbiology. https://doi.org/10.1038/s41564-018-0257-9
2. The composition of gut bacteria almost recovers after antibiotics. ScienceDaily. https://www.sciencedaily.com/releases/2018/10/181023110545.htm
3. Antibiotic use linked to 'persistent' gut microbiome changes. cidrap.umn.edu. https://www.cidrap.umn.edu/antimicrobial-stewardship/antibiotic-use-linked-persistent-gut-microbiome-changes
4. Skye R. S. Fishbein, Bejan Mahmud, Gautam Dantas (2023). Antibiotic perturbations to the gut microbiome. Nature Reviews Microbiology. https://doi.org/10.1038/s41579-023-00933-y